LCM
APRE icon

Landscape Capital Management’s Aprea Therapeutics APRE Stock Holding History

Landscape Capital Management’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,496
Closed -$15.5K – 714
2025
Q3 		$15.5K Sell
10,496
-13,473
-56% -$22.2K ﹤0.01% 591
2025
Q2 		$40.5K Sell
23,969
-6,909
-22% -$11.8K ﹤0.01% 623
2025
Q1 		$63K Sell
30,878
-4,450
-13% -$13.9K 0.01% 595
2024
Q4 		$116K Buy
+35,328
New +$118K 0.01% 651

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Landscape Capital Management's APRE Position: Q4 2025 in Review

Landscape Capital Management sold out of Aprea Therapeutics (APRE) in Q4 2025, closing a stake of 10,496 shares — an estimated $15.5K sold.

Landscape Capital Management first reported a position in APRE in Q4 2024 and held it in 4 quarters. The position peaked at $116K in Q4 2024. 22 funds tracked by Wall St. Rank hold APRE as of Q4 2025.

  • Landscape Capital Management reported no remaining Aprea Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Landscape Capital Management sold 10,496 Aprea Therapeutics shares in Q4 2025, an estimated $15.5K.
  • Landscape Capital Management first reported a position in Aprea Therapeutics in Q4 2024 and held it in 4 quarters.
  • Landscape Capital Management's Aprea Therapeutics position peaked at $116K in Q4 2024.
  • 22 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q4 2025.

Based on Landscape Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.